DXCM Dexcom Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: DXCM

Price (delayed)

$77.67

Market cap

$30.49B

P/E Ratio

141.22

Dividend/share

N/A

EPS

$0.55

Enterprise value

$31.85B

DexCom, Inc. is a company that develops, manufactures, and distributes continuous glucose monitoring systems for diabetes management. It operates internationally with headquarters in San Diego, California. Dexcom was founded in ...

Highlights
DXCM's gross profit is up by 27% year-on-year and by 3.2% since the previous quarter
Dexcom's revenue has increased by 27% YoY and by 5% from the previous quarter
The EPS has shrunk by 61% YoY but it rose by 38% QoQ
Dexcom's net income has plunged by 60% YoY but it has increased by 37% from the previous quarter
The debt has increased by 14% YoY
The quick ratio has declined by 11% year-on-year
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.dexcom.com/
Peers: EW BDX WST TNDM

Key stats

What are the main financial stats of DXCM
Market
Shares outstanding
392.5M
Market cap
$30.49B
Enterprise value
$31.85B
Valuations
Price to earnings (P/E)
141.22
Price to book (P/B)
13.77
Price to sales (P/S)
11.74
EV/EBIT
116.92
EV/EBITDA
81.6
EV/Sales
12.38
Earnings
Revenue
$2.57B
EBIT
$272.4M
EBITDA
$390.3M
Free cash flow
$94.6M
Per share
EPS
$0.55
Free cash flow per share
$0.24
Book value per share
$5.64
Revenue per share
$6.62
TBVPS
$12.86
Balance sheet
Total assets
$5.06B
Total liabilities
$2.87B
Debt
$2.08B
Equity
$2.19B
Working capital
$3.04B
Liquidity
Debt to equity
0.95
Current ratio
5.27
Quick ratio
4.54
Net debt/EBITDA
3.5
Margins
EBITDA margin
15.2%
Gross margin
67.4%
Net margin
8.2%
Operating margin
10.2%
Efficiency
Return on assets
4.4%
Return on equity
10.1%
Return on invested capital
5.5%
Return on capital employed
6.3%
Return on sales
10.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

DXCM stock price

How has the Dexcom stock price performed over time
Intraday
3.27%
1 week
12.88%
1 month
7.83%
1 year
-26.9%
YTD
-42.14%
QTD
-39.27%

Financial performance

How have Dexcom's revenue and profit performed over time
Revenue
$2.57B
Gross profit
$1.73B
Operating income
$261.2M
Net income
$211.7M
Gross margin
67.4%
Net margin
8.2%
The net margin has plunged by 69% YoY but it has increased by 30% from the previous quarter
Dexcom's net income has plunged by 60% YoY but it has increased by 37% from the previous quarter
The operating margin has declined by 34% year-on-year and by 6% since the previous quarter
DXCM's gross profit is up by 27% year-on-year and by 3.2% since the previous quarter

Growth

What is Dexcom's growth rate over time

Valuation

What is Dexcom stock price valuation
P/E
141.22
P/B
13.77
P/S
11.74
EV/EBIT
116.92
EV/EBITDA
81.6
EV/Sales
12.38
The EPS has shrunk by 61% YoY but it rose by 38% QoQ
The stock's price to earnings (P/E) is 23% less than its last 4 quarters average of 184.5
DXCM's P/B is 41% below its last 4 quarters average of 23.4 and 31% below its 5-year quarterly average of 20.0
The company's equity rose by 15% YoY and by 7% QoQ
The stock's price to sales (P/S) is 43% less than its last 4 quarters average of 20.6 and 18% less than its 5-year quarterly average of 14.4
Dexcom's revenue has increased by 27% YoY and by 5% from the previous quarter

Efficiency

How efficient is Dexcom business performance
The ROE has dropped by 69% year-on-year but it is up by 31% since the previous quarter
Dexcom's ROA has plunged by 67% YoY but it has increased by 33% from the previous quarter
The ROS fell by 31% YoY and by 6% QoQ
DXCM's return on invested capital is down by 19% year-on-year and by 5% since the previous quarter

Dividends

What is DXCM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for DXCM.

Financial health

How did Dexcom financials performed over time
The company's total assets is 76% higher than its total liabilities
The company's total assets rose by 15% YoY and by 2.5% QoQ
The total liabilities has increased by 15% year-on-year
The debt is 5% less than the equity
The company's equity rose by 15% YoY and by 7% QoQ
The debt has increased by 14% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.